Boston-based personalized health improvement technology maker Healthrageous received Series B financing from Partners Innovation Fund, part of Partners HealthCare.
The new funds complete Parters’ incubation role, Healthrageous reported.
Shares of Johnson & Johnson (NYSE:JNJ) surged to a 52-week high today after the healthcare conglomerate boosted its 2012 earnings forecast after reporting a solid, Street-beating quarter (and despite a nearly 18% bottom-line slide).
Healthrageous, the creator of a multi-tiered personalized health management tool, raised $6 million in a Series A equity sale.
North Bridge Venture Partners of Boston led the round and was joined by fellow Boston-based firm Egan Managed Capital and Long River Ventures of Amherst, Mass.
According to an SEC filing all of the $6 million in equity made available was sold.